Strides Shasun receives FDA approval for Abacavir Tablets
November 02, 2016 | Wednesday | News | By BioSpectrum Bureau
Strides Shasun receives FDA approval for Abacavir Tablets
Strides Shasun Limited has announced that it has received approval from the United States Food & Drug Administration (USFDA) for Abacavir Tablets USP, 300 mg
According to IMS data, the US market for Abacavir is approximately $30 Million.
The product will be manufactured at the Company's USFDA approved facility at Bangalore and marketed by Strides in the US Market. The product will be launched immediately.
Abacavir Tablets is indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents
